Atlantic Research Group

Executive Summary

Atlantic Research Group (ARG) is a US-based contract research organization (CRO) founded in 2004, specializing in complex clinical trials across oncology, immunology, and neurology. The company recently merged with Evestia Clinical to create a larger, global specialist CRO, enhancing its capabilities and geographic reach. ARG's deep expertise in challenging therapeutic areas positions it as a valued partner for biopharmaceutical sponsors seeking high-quality trial execution. The merger is expected to drive operational efficiencies and broaden the service portfolio, strengthening ARG's competitive positioning in the fragmented CRO market. The combined entity benefits from synergies in patient recruitment, regulatory expertise, and technology platforms, enabling faster trial timelines and cost-effective solutions. With the global CRO market projected to grow steadily, ARG is well-positioned to capture demand from emerging biotechs and established pharma companies. However, integration risks and competitive pressures remain challenges. The company's private status limits visibility, but its niche focus and recent consolidation suggest a solid foundation for sustainable growth.

Upcoming Catalysts (preview)

• Q3 2026Completion of Merger Integration with Evestia Clinical85% success
• TBDAnnouncement of Major New Contracts in Oncology or Neurology60% success
• Q4 2026Expansion into New Therapeutic Areas or Geographic Markets50% success